Michael D. Mulholland
2017 - CytoDyn
In 2017, Michael D. Mulholland earned a total compensation of $677.2K as Chief Financial Officer at CytoDyn, a 19% decrease compared to previous year.
Compensation breakdown
| Bonus | $101,250 |
|---|---|
| Option Awards | $228,330 |
| Salary | $337,500 |
| Other | $10,125 |
| Total | $677,205 |
Mulholland received $337.5K in salary, accounting for 50% of the total pay in 2017.
Mulholland also received $101.3K in bonus, $228.3K in option awards and $10.1K in other compensation.
Rankings
In 2017, Michael D. Mulholland's compensation ranked 10,752nd out of 14,666 executives tracked by ExecPay. In other words, Mulholland earned more than 26.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,752 out of 14,666 | 27th |
Division Manufacturing | 4,189 out of 5,772 | 27th |
Major group Chemicals And Allied Products | 1,497 out of 2,075 | 28th |
Industry group Drugs | 1,224 out of 1,731 | 29th |
Industry Pharmaceutical Preparations | 951 out of 1,333 | 29th |
Source: SEC filing on July 24, 2017.
Mulholland's colleagues
We found two more compensation records of executives who worked with Michael D. Mulholland at CytoDyn in 2017.